Prostate cancer drug now available to more patients with aggressive form of disease
1 year ago
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.
Click here to Read more
Related Health Updates:
